학술논문
HSD20 Real-World Treatment Patterns and Outcomes After Introduction of Immune Checkpoint Inhibitors (ICIs) in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Europe (EU4+UK)
Document Type
Abstract
Author
Source
In Value in Health December 2022 25(12) Supplement:S277-S277
Subject
Language
ISSN
1098-3015